Our Pricing

Private Mounjaro Prescription - Skip NHS Waiting Lists

Published on: June 03, 2026

Securing a private mounjaro prescription UK online has become the preferred route for thousands of patients facing lengthy NHS waiting lists. At Cured Pharmacy, our UK-registered prescribers assess your suitability in under 3 minutes, with genuine Mounjaro (tirzepatide) KwikPens dispensed from £124.99—transparent pricing shown before you begin.

How Mounjaro Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Unlike single-pathway treatments such as semaglutide, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, producing synergistic effects on appetite regulation, gastric emptying, and insulin secretion.

In the landmark SURPASS-3 trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks—substantially higher than comparator agents [1]. The dual-receptor mechanism appears to enhance satiety signals more effectively than GLP-1 agonism alone, whilst maintaining favourable glycaemic control in patients with type 2 diabetes [2].

Private Mounjaro Prescription UK: The Assessment Process

Every Mounjaro prescription at Cured Pharmacy begins with a clinical assessment by a UK-registered prescriber, ensuring the treatment is safe and appropriate for your circumstances. Our online consultation takes under 3 minutes and covers your medical history, current medications, weight management goals, and any contraindications.

Your responses are reviewed by our clinical team—overseen by superintendent pharmacist Tarun Kumar (GPhC 2233073)—who will determine your suitability and starting dose. If approved, your prescription is issued electronically and dispensed from our GPhC-registered pharmacy (9012511) with discreet next-day delivery across the UK.

Who Can Request a Private Prescription?

Mounjaro is licensed for adults with a body mass index (BMI) of 30 kg/m² or above, or 27 kg/m² with at least one weight-related comorbidity such as hypertension or type 2 diabetes [3]. Your prescriber will assess whether you meet NICE eligibility criteria and have no contraindications, including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Mounjaro vs Wegovy: Comparing Dual and Single Receptor Agonists

Both Mounjaro and Wegovy are weekly injectable treatments licensed in the UK for chronic weight management, yet they differ fundamentally in their receptor activity. Wegovy contains semaglutide, a selective GLP-1 receptor agonist, whilst Mounjaro's tirzepatide targets both GIP and GLP-1 pathways simultaneously.

Head-to-head data from the SURPASS-2 trial demonstrated superior weight loss with tirzepatide compared to semaglutide 1mg, with the 15mg tirzepatide dose producing approximately 6% greater mean body weight reduction at 40 weeks [4]. However, individual response varies, and some patients may prefer semaglutide's longer clinical track record or lower starting price point.

Choosing Between Mounjaro and Wegovy

Your UK prescriber will consider several factors when recommending a treatment, including your weight loss goals, previous medication response, injection frequency preference, and budget. Both medications require dose escalation to minimise gastrointestinal side effects, and both are contraindicated in pregnancy. Our clinical team can guide you through the options during your free consultation.

Mounjaro Pricing: What to Expect from a Private Prescription

At Cured Pharmacy, Mounjaro is priced from £124.99 per pen, with transparent costs displayed before you begin your consultation. The exact price depends on your prescribed dose—starting doses (2.5mg) are typically lower in cost, whilst maintenance doses (10mg, 12.5mg, 15mg) reflect higher medication volumes.

We guarantee the lowest prices in the UK and never apply hidden consultation fees or membership charges. Your total cost includes the clinical assessment, prescription, genuine UK-licensed medication, and discreet delivery—no surprises at checkout.

How to Start Your Private Mounjaro Prescription Today

Beginning treatment is straightforward: complete our 3-minute online consultation, receive a clinical decision within hours, and have your Mounjaro pen dispatched the same day if approved. All packaging is 100% discreet, with no external branding or medication names visible.

Our clinical team is available by phone on (+44) 116 4646009 if you have questions about the assessment process, dosing schedules, or potential side effects. Every prescription is reviewed individually—there are no automatic approvals, ensuring patient safety remains our priority.

Ongoing Support and Prescription Renewals

Weight management with Mounjaro typically requires ongoing treatment, with dose escalation every 4 weeks until you reach your maintenance dose. Our prescribers offer prescription renewals subject to clinical review, ensuring your progress is monitored and any side effects are managed appropriately. You can reorder through your online account, with the same discreet delivery service for every prescription.

Common Mounjaro Side Effects and How to Manage Them

The most frequently reported side effects of tirzepatide are gastrointestinal: nausea, diarrhoea, vomiting, constipation, and abdominal discomfort [1]. These symptoms are typically mild to moderate, occur most often during dose escalation, and diminish over time as your body adapts to the medication.

To minimise gastrointestinal effects, eat smaller, more frequent meals, avoid high-fat foods, and stay well-hydrated. If nausea persists, your prescriber may recommend a slower dose escalation schedule. Serious side effects are rare but include pancreatitis, gallbladder disease, and hypoglycaemia (particularly if you take other glucose-lowering medications)—seek immediate medical attention if you experience severe abdominal pain, persistent vomiting, or signs of low blood sugar [5].

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Frias, J. P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2): a randomised, open-label, phase 3 trial. The Lancet, 398(10295), 64–77. https://doi.org/10.1016/S0140-6736(21)01324-6 [accessed 13 August 2026]
3. Medicines and Healthcare products Regulatory Agency (MHRA). (2023). Public Assessment Report: Mounjaro 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg solution for injection in pre-filled pen. GOV.UK. [accessed 13 August 2026]
4. Ludvik, B., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583–598. https://doi.org/10.1016/S0140-6736(21)01443-4 [accessed 13 August 2026]
5. Electronic Medicines Compendium (EMC). (2024). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC). Datapharm Ltd. [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.